Safety and Efficacy of Cryoablation With Karelizumab and Apatinib for Multiple Lung Cancers

NCT06607770 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zhou Chengzhi